Cargando…

Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B+

BACKGROUND: Antiretroviral therapy (ART) adherence in preventing HIV mother-to-child transmission in association with virological suppression and risk factors of low adherence in the Cameroon’s Option B+ programme are poorly understood. We used a composite adherence score (CAS) to determine adherenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Atanga, Pascal N., Ndetan, Harrison T., Fon, Peter N., Meriki, Henry D., Muffih, Tih P., Achidi, Eric A., Hoelscher, Michael, Kroidl, Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202832/
https://www.ncbi.nlm.nih.gov/pubmed/30359239
http://dx.doi.org/10.1186/s12884-018-2058-9
_version_ 1783365764592435200
author Atanga, Pascal N.
Ndetan, Harrison T.
Fon, Peter N.
Meriki, Henry D.
Muffih, Tih P.
Achidi, Eric A.
Hoelscher, Michael
Kroidl, Arne
author_facet Atanga, Pascal N.
Ndetan, Harrison T.
Fon, Peter N.
Meriki, Henry D.
Muffih, Tih P.
Achidi, Eric A.
Hoelscher, Michael
Kroidl, Arne
author_sort Atanga, Pascal N.
collection PubMed
description BACKGROUND: Antiretroviral therapy (ART) adherence in preventing HIV mother-to-child transmission in association with virological suppression and risk factors of low adherence in the Cameroon’s Option B+ programme are poorly understood. We used a composite adherence score (CAS) to determine adherence and risk factors of poor adherence in association with virological treatment response in HIV-positive pregnant and breastfeeding women who remained in care at 6 and 12 months after initiating ART. METHODS: We prospectively enrolled 268 women after ART initiation between October 2013 and December 2015 from five facilities within the Kumba health district. Adherence at 6 and 12 months were measured using a CAS comprising of a 6-month medication refill record review, a four-item self-reported questionnaires and a 30-day visual analogue scale. Adherence was defined as the sum scores of the three measures and classified as high, moderate and low. Measured adherence levels were compared to virological suppression rates at month 12 and risk factors of poor adherence were determined. RESULTS: At 6 and 12 months, 217 (81.0%) and 185 (69.0%) women were available for adherence evaluation. Respectively. Of those, 128 (59.0%) and 68 (31.4%) had high or moderate adherence as per the CAS tool at month 6, and 116 (62.7%) and 48 (24.9%) at month 12, respectively. Viral loads were assessed in 165 women at months 12, and 92.7% had viral suppression (< 1000 copies/mL). Viral suppression was seen in 100% of women with high, 89.5% with moderate, and 52.9% with low adherence using the CAS tool. Virological treatment failure was significantly associated with low adherence [OR 7.6, (95%CI, 1.8–30.8)]. Risk factors for low adherence were younger age [aOR 3.8, (95%CI, 1.4–10.6)], primary as compared to higher levels of education [aOR 2.7, (95%CI, 1.4–5.2)] and employment in the informal sector compared to unemployment [aOR 1.9, (95%CI,1.0–3.6)]. CONCLUSIONS: During the first year of Option B+ implementation in Cameroon our novel CAS adherence tool was feasible, and useful to discriminate ART adherence levels which correlated with viral suppression. Younger age, less educated and informal sector employed women may need more attention for optimal adherence to reduce the risk of virological failure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12884-018-2058-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6202832
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62028322018-11-01 Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B+ Atanga, Pascal N. Ndetan, Harrison T. Fon, Peter N. Meriki, Henry D. Muffih, Tih P. Achidi, Eric A. Hoelscher, Michael Kroidl, Arne BMC Pregnancy Childbirth Research Article BACKGROUND: Antiretroviral therapy (ART) adherence in preventing HIV mother-to-child transmission in association with virological suppression and risk factors of low adherence in the Cameroon’s Option B+ programme are poorly understood. We used a composite adherence score (CAS) to determine adherence and risk factors of poor adherence in association with virological treatment response in HIV-positive pregnant and breastfeeding women who remained in care at 6 and 12 months after initiating ART. METHODS: We prospectively enrolled 268 women after ART initiation between October 2013 and December 2015 from five facilities within the Kumba health district. Adherence at 6 and 12 months were measured using a CAS comprising of a 6-month medication refill record review, a four-item self-reported questionnaires and a 30-day visual analogue scale. Adherence was defined as the sum scores of the three measures and classified as high, moderate and low. Measured adherence levels were compared to virological suppression rates at month 12 and risk factors of poor adherence were determined. RESULTS: At 6 and 12 months, 217 (81.0%) and 185 (69.0%) women were available for adherence evaluation. Respectively. Of those, 128 (59.0%) and 68 (31.4%) had high or moderate adherence as per the CAS tool at month 6, and 116 (62.7%) and 48 (24.9%) at month 12, respectively. Viral loads were assessed in 165 women at months 12, and 92.7% had viral suppression (< 1000 copies/mL). Viral suppression was seen in 100% of women with high, 89.5% with moderate, and 52.9% with low adherence using the CAS tool. Virological treatment failure was significantly associated with low adherence [OR 7.6, (95%CI, 1.8–30.8)]. Risk factors for low adherence were younger age [aOR 3.8, (95%CI, 1.4–10.6)], primary as compared to higher levels of education [aOR 2.7, (95%CI, 1.4–5.2)] and employment in the informal sector compared to unemployment [aOR 1.9, (95%CI,1.0–3.6)]. CONCLUSIONS: During the first year of Option B+ implementation in Cameroon our novel CAS adherence tool was feasible, and useful to discriminate ART adherence levels which correlated with viral suppression. Younger age, less educated and informal sector employed women may need more attention for optimal adherence to reduce the risk of virological failure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12884-018-2058-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-25 /pmc/articles/PMC6202832/ /pubmed/30359239 http://dx.doi.org/10.1186/s12884-018-2058-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Atanga, Pascal N.
Ndetan, Harrison T.
Fon, Peter N.
Meriki, Henry D.
Muffih, Tih P.
Achidi, Eric A.
Hoelscher, Michael
Kroidl, Arne
Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B+
title Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B+
title_full Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B+
title_fullStr Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B+
title_full_unstemmed Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B+
title_short Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B+
title_sort using a composite adherence tool to assess art response and risk factors of poor adherence in pregnant and breastfeeding hiv-positive cameroonian women at 6 and 12 months after initiating option b+
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202832/
https://www.ncbi.nlm.nih.gov/pubmed/30359239
http://dx.doi.org/10.1186/s12884-018-2058-9
work_keys_str_mv AT atangapascaln usingacompositeadherencetooltoassessartresponseandriskfactorsofpooradherenceinpregnantandbreastfeedinghivpositivecameroonianwomenat6and12monthsafterinitiatingoptionb
AT ndetanharrisont usingacompositeadherencetooltoassessartresponseandriskfactorsofpooradherenceinpregnantandbreastfeedinghivpositivecameroonianwomenat6and12monthsafterinitiatingoptionb
AT fonpetern usingacompositeadherencetooltoassessartresponseandriskfactorsofpooradherenceinpregnantandbreastfeedinghivpositivecameroonianwomenat6and12monthsafterinitiatingoptionb
AT merikihenryd usingacompositeadherencetooltoassessartresponseandriskfactorsofpooradherenceinpregnantandbreastfeedinghivpositivecameroonianwomenat6and12monthsafterinitiatingoptionb
AT muffihtihp usingacompositeadherencetooltoassessartresponseandriskfactorsofpooradherenceinpregnantandbreastfeedinghivpositivecameroonianwomenat6and12monthsafterinitiatingoptionb
AT achidierica usingacompositeadherencetooltoassessartresponseandriskfactorsofpooradherenceinpregnantandbreastfeedinghivpositivecameroonianwomenat6and12monthsafterinitiatingoptionb
AT hoelschermichael usingacompositeadherencetooltoassessartresponseandriskfactorsofpooradherenceinpregnantandbreastfeedinghivpositivecameroonianwomenat6and12monthsafterinitiatingoptionb
AT kroidlarne usingacompositeadherencetooltoassessartresponseandriskfactorsofpooradherenceinpregnantandbreastfeedinghivpositivecameroonianwomenat6and12monthsafterinitiatingoptionb